NSE · OAL · Chemicals
Oriental Aromatics Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹279 Cr with net profit ₹9 Cr — a 3.28% net margin, versus 1.44% the period before.
Shareholding
As of 2026-06-30
- Promoter74.17%
- Public25.81%
- FII0.02%
- DII0%
23,728 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 1.75× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Chemicals · ranked #55 of 159 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Pidilite Industries Ltd. | ₹1,65,890 Cr | 286.45 | 15.31 | 22.61% | 16.77% |
| Solar Industries India Ltd. | ₹1,63,606 Cr | 298.74 | 26.05 | 26.72% | 17.05% |
| SRF Ltd. | ₹78,369 Cr | 134.68 | 5.58 | 13.07% | 13.01% |
| Linde India Limited | ₹57,332 Cr | 104.57 | 13.44 | 12.87% | 21.69% |
| Gujarat Fluorochemicals Ltd. | ₹50,334 Cr | 461.91 | 6.45 | 7.3% | 11.49% |
| Godrej Industries Ltd. | ₹43,559 Cr | 98.05 | 3.9 | 11.1% | 5.58% |
| Navin Fluorine International Ltd. | ₹38,965 Cr | 183.04 | 9.8 | 16.69% | 20.02% |
| Himadri Speciality Chem Limited | ₹38,845 Cr | 193.44 | 8.25 | 15.96% | 16.12% |
| Deepak Nitrite Ltd. | ₹22,840 Cr | 103.95 | 3.91 | 9.43% | 6.98% |
| Deepak Fertilisers & Petrochemicals Corp Ltd. | ₹20,530 Cr | 147.31 | 3 | 10.77% | 6.41% |
| Oriental Aromatics Ltd.(this company) | ₹1,341 Cr | 337.67 | 2.01 | 0.5% | 0.32% |
AI analysis
AI-generated · google/gemini-2.5-flashOriental Aromatics Ltd. operates with a market capitalization of Rs 1181 Cr. The company reported annual revenue of Rs 931.53 Cr with an 11% growth. Its profit margin stands at 32.1%, and diluted EPS is Rs 0.98. The 52-week high for the share price was Rs 421.3 and the 52-week low was Rs 228.
Positives
- +Promoter shareholding is high at 74.17% as of March 31, 2026, indicating confidence from the promoters.
- +The debt-to-equity ratio is 0.43, suggesting a manageable level of debt.
- +The company's profit margin is 32.1%, indicating efficient operations.
- +The Return on Equity (ROE) is 49.8%, indicating effective utilization of shareholders' funds.
Negatives
- −The Return on Capital Employed (ROCE) is relatively low at 4.36%.
- −Net profit in December 2025 was negative at -Rs 1.92 Cr.
- −The diluted EPS is low at Rs 0.98.
Financial performance
Oriental Aromatics Ltd. reported an annual revenue of Rs 931.53 Cr, demonstrating an 11% growth. The annual net profit stands at Rs 33.47 Cr (derived from profit margin * revenue). The company's EPS is Rs 0.98. Quarterly revenue for the period ending March 2026 was Rs 282.37 Cr, with a net profit of Rs 3.99 Cr. The company experienced a brief period of negative net profit in December 2025 at -Rs 1.92 Cr.
Profitability & returns
The company's profit margin is 32.1%. Return on equity (ROE) is 49.8%. The Return on Capital Employed (ROCE) is 4.36%. Looking at recent quarterly data, the net profit for March 2026 was Rs 3.99 Cr, improving from a negative net profit of Rs -1.92 Cr in December 2025.
Balance sheet
Oriental Aromatics Ltd. has a book value of Rs 197.46 per share. The debt-to-equity ratio is 0.43, indicating a moderate level of leverage. No information on total debt or total assets was provided.
Ownership & pledges
Public shareholding is 25.83%. There are no pledged promoter shares.
Regulatory & surveillance
Oriental Aromatics Ltd. is not currently under any surveillance measure.
Data as of — price: 2026-07-30 · financials: Mar 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.